Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.

Loading...

Date

2011-11-23

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

174
views
448
downloads

Citation Stats

Attention Stats

Abstract

Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary sequence diversity and N-linked glycosylation. Human antibodies such as PG9 nonetheless engage V1/V2 and neutralize 80% of HIV-1 isolates. Here we report the structure of V1/V2 in complex with PG9. V1/V2 forms a four-stranded β-sheet domain, in which sequence diversity and glycosylation are largely segregated to strand-connecting loops. PG9 recognition involves electrostatic, sequence-independent and glycan interactions: the latter account for over half the interactive surface but are of sufficiently weak affinity to avoid autoreactivity. The structures of V1/V2-directed antibodies CH04 and PGT145 indicate that they share a common mode of glycan penetration by extended anionic loops. In addition to structurally defining V1/V2, the results thus identify a paradigm of antibody recognition for highly glycosylated antigens, which-with PG9-involves a site of vulnerability comprising just two glycans and a strand.

Department

Description

Provenance

Subjects

AIDS Vaccines, Amino Acid Motifs, Amino Acid Sequence, Antibodies, Neutralizing, Antibody Affinity, Antibody Specificity, Antigen-Antibody Complex, Binding Sites, Antibody, Conserved Sequence, Crystallography, X-Ray, Epitopes, Glycopeptides, Glycosylation, HIV Antibodies, HIV Envelope Protein gp120, HIV-1, Hydrogen Bonding, Immune Evasion, Models, Molecular, Molecular Sequence Data, Polysaccharides, Protein Structure, Quaternary, Protein Structure, Tertiary

Citation

Published Version (Please cite this version)

10.1038/nature10696

Publication Info

McLellan, JS, M Pancera, C Carrico, J Gorman, JP Julien, R Khayat, R Louder, R Pejchal, et al. (2011). Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature, 480(7377). pp. 336–343. 10.1038/nature10696 Retrieved from https://hdl.handle.net/10161/13795.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Crump

John Andrew Crump

Adjunct Professor in the Department of Medicine

I am an Adjunct Professor of Medicine, Pathology, and Global Health. My work with Duke University is primarily based in northern Tanzania where I am former Site Leader and current Principal Investigator on projects linked to Duke University’s collaborative research program at Kilimanjaro Christian Medical Centre. I oversee the design and implementation of research studies on infectious diseases, particularly febrile illness, invasive bacterial disease, zoonotic infections, and infectious diseases diagnostics. In addition, I am Professor of Medicine, Pathology, and Global Health at the University of Otago and a medical epidemiologist with the US Centers for Disease Control and Prevention (CDC). My CDC work focuses on non-malaria febrile illness.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.